ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Relay Therapeutics Inc

Relay Therapeutics Inc (RLAY)

3,66
0,25
(7,33%)
Geschlossen 15 März 9:00PM
3,59
-0,07
(-1,91%)
Nach Börsenschluss: 12:55AM

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
3,59
Gebot
3,50
Fragen
3,60
Volumen
2.128.586
3,35 Tagesbereich 3,66
3,02 52-Wochen-Bereich 10,72
Marktkapitalisierung
Handelsende
3,41
Handelsbeginn
3,40
Letzte Trade
5
@
3.6
Letzter Handelszeitpunkt
Finanzvolumen
US$ 7.399.262
VWAP
3,4761
Durchschnittliches Volumen (3 Mio.)
2.242.503
Ausgegebene Aktien
169.521.849
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-1,81
Gewinn pro Aktie (EPS)
-2,02
Erlöse
31,97M
Nettogewinn
-341,97M

Über Relay Therapeutics Inc

Relay Therapeutics Inc is a clinical-stage, precision medicines company transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. The company is advancing its pipeline of medicines to address targets in precision oncology, i... Relay Therapeutics Inc is a clinical-stage, precision medicines company transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. The company is advancing its pipeline of medicines to address targets in precision oncology, including its lead product candidates, RLY-4008 and RLY-1971, as well as its PI3Ka mutant selective program, known as the RLY-PI3K1047 program. Its initiated a Phase 1 clinical trial for RLY-1971 in patients with advanced solid tumors in the first quarter of 2020 and a first-in-human clinical trial of RLY-4008 enriched for patients with advanced solid tumors having oncogenic FGFR2 alterations in the third quarter of 2020. Mehr anzeigen

Sektor
Biological Pds,ex Diagnstics
Branche
Biological Pds,ex Diagnstics
Website
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Relay Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker RLAY. The last closing price for Relay Therapeutics was US$3,41. Over the last year, Relay Therapeutics shares have traded in a share price range of US$ 3,02 to US$ 10,72.

Relay Therapeutics currently has 169.521.849 shares in issue. The market capitalisation of Relay Therapeutics is US$578,07 million. Relay Therapeutics has a price to earnings ratio (PE ratio) of -1.81.

RLAY Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.195.588235294123.43.913.0926519073.45683259CS
4-0.36-9.113924050633.954.243.0221540663.52660673CS
12-0.65-15.33018867924.245.993.0222425034.10563789CS
26-4.56-55.95092024548.158.3153.0220623494.96245926CS
52-5.44-60.24363233679.0310.723.0218035036.08318099CS
156-19.95-84.749362786723.5435.363.02137903911.40260144CS
260-30.39-89.434961742233.9864.373.02109288715.95880733CS

RLAY - Frequently Asked Questions (FAQ)

What is the current Relay Therapeutics share price?
The current share price of Relay Therapeutics is US$ 3,59
How many Relay Therapeutics shares are in issue?
Relay Therapeutics has 169.521.849 shares in issue
What is the market cap of Relay Therapeutics?
The market capitalisation of Relay Therapeutics is USD 578,07M
What is the 1 year trading range for Relay Therapeutics share price?
Relay Therapeutics has traded in the range of US$ 3,02 to US$ 10,72 during the past year
What is the PE ratio of Relay Therapeutics?
The price to earnings ratio of Relay Therapeutics is -1,81
What is the cash to sales ratio of Relay Therapeutics?
The cash to sales ratio of Relay Therapeutics is 19,41
What is the reporting currency for Relay Therapeutics?
Relay Therapeutics reports financial results in USD
What is the latest annual turnover for Relay Therapeutics?
The latest annual turnover of Relay Therapeutics is USD 31,97M
What is the latest annual profit for Relay Therapeutics?
The latest annual profit of Relay Therapeutics is USD -341,97M
What is the registered address of Relay Therapeutics?
The registered address for Relay Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the Relay Therapeutics website address?
The website address for Relay Therapeutics is www.relaytx.com
Which industry sector does Relay Therapeutics operate in?
Relay Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
RDUSRadius Recycling Inc
US$ 27,902
(104,26%)
8,53M
BONBon Natural Life Ltd
US$ 1,40
(90,29%)
84M
SUNESUNation Energy Inc
US$ 0,5213
(62,96%)
513,96M
WHLRLWheeler Real Estate Investment Trust Inc
US$ 255,00
(39,80%)
222
AAOIApplied Optoelectronics Inc
US$ 22,105
(39,29%)
17,01M
GLSTUGlobal Star Acquisition Inc
US$ 2,00
(-69,23%)
421
CURRCurrenc Group Inc
US$ 2,03
(-41,33%)
1,42M
ADTXAditxt Inc
US$ 0,0201
(-39,82%)
240,2M
HEPAHepion Pharmaceuticals Inc
US$ 0,0228
(-39,68%)
161,52M
WKSPWorksport Ltd
US$ 0,36205
(-35,45%)
4,96M
SUNESUNation Energy Inc
US$ 0,5213
(62,96%)
513,96M
NVDANVIDIA Corporation
US$ 121,67
(5,27%)
277,56M
ADTXAditxt Inc
US$ 0,0201
(-39,82%)
240,2M
HEPAHepion Pharmaceuticals Inc
US$ 0,0228
(-39,68%)
161,52M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 9,225
(7,64%)
160,21M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen